Sen. Murphy visits Shelton Biotech company
U.S. Senator Chris Murphy (D-Conn.) visited NanoViricides, Inc., a Shelton-based company working to develop nanotechnology-based anti-viral medicines, on Wednesday. Murphy joined founder Dr. Anil Diwan for a tour of the facility and then hosted a town hall with the company’s thirty employees. Two years ago, NanoViricides expanded to their new Shelton lab space from a smaller West Haven facility and added twenty new employees. NanoViricides is currently working on anti-viral drugs to treat a number of diseases, including Zika, H1N1, influenza, and Ebola, as well as a skin cream for treating shingles.
“NanoViricides is exactly the type of innovative company driving job creation throughout greater New Haven and the Naugatuck Valley,” said Senator Murphy. “I was incredibly impressed by the company and enjoyed hearing from employees during my town hall about how I can best help them and other bioscience entrepreneurs cut through red tape. I know the success of our state’s economy is reliant on innovative companies like NanoViricides that tap into the strengths of our state’s workforce and educational institutions, and I’ll be bringing what I learned from today’s visit back to Congress.”
“We really appreciate Senator Murphy for visiting and wanting to learn about NanoViricides. We are excited about the future opportunities with our highly-effective nanotechnology, and we’re happy to know the Senator is as well,” said Dr. Diwan.